Authors:
Islam, M
Burke, JF
McGowan, TA
Zhu, YQ
Dunn, SR
McCue, P
Kanalas, J
Sharma, K
Citation: M. Islam et al., Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction, KIDNEY INT, 59(2), 2001, pp. 498-506
Citation: Ta. Mcgowan et K. Sharma, Regulation of inositol 1,4,5-trisphosphate receptors by transforming growth factor-beta: Implications for vascular dysfunction in diabetes, KIDNEY INT, 58, 2000, pp. S99-S103
Authors:
Ziyadeh, FN
Hoffman, BB
Han, DC
Iglesias-de la Cruz, MC
Hong, SW
Isono, M
Chen, S
McGowan, TA
Sharma, K
Citation: Fn. Ziyadeh et al., Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice, P NAS US, 97(14), 2000, pp. 8015-8020
Authors:
Sharma, K
Eltayeb, BO
McGowan, TA
Dunn, SR
Alzahabi, B
Rohde, R
Ziyadeh, FN
Lewis, EJ
Citation: K. Sharma et al., Captopril-induced reduction of serum levels of transforming growth factor-beta 1 correlates with long-term renoprotection in insulin-dependent diabetic patients, AM J KIDNEY, 34(5), 1999, pp. 818-823